Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1871727

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1871727

Ibuprofen API Market Size, Share, and Growth Analysis, By Application (Pharmaceuticals, Consumer Healthcare), By Formulation Type (Tablets, Oral), By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Ibuprofen API Market size was valued at USD 6.2 billion in 2023 and is poised to grow from USD 6.46 billion in 2024 to USD 8.98 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, an aging demographic, and the widespread adoption of generic medications. A surge in demand for anti-inflammatory and analgesic products across both prescription and over-the-counter sectors contributes to this upward trend. Key factors fueling this expansion include the global aging population, enhanced healthcare accessibility, and a preference for cost-effective generic options. North America and Europe hold substantial market shares due to sustained interest in premium APIs, although challenges such as fluctuating raw material costs and regulatory hurdles may threaten operational consistency. The outlook remains optimistic, particularly in the Asia Pacific region, which is poised to lead in production capacity and export volume, influencing market trends in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth, primarily fueled by the rising demand for cost-effective pain relief and anti-inflammatory drugs. The emergence of generic formulations, facilitated by the expiration of patents and efforts to make healthcare more affordable, bolsters market accessibility. Additionally, an aging population and a higher prevalence of chronic pain conditions and inflammation-related disorders further drive the expansion of this market, enhancing both its size and revenue potential. Overall, these factors combine to create a robust environment for the growth and development of Ibuprofen API products worldwide.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to fluctuations in the prices of essential precursors, such as isobutyl benzene and acetyl chloride. These price variations can directly impact production costs and overall profitability, particularly for small- and medium-sized manufacturers. Additionally, the reliance on a limited number of suppliers heightens the exposure to supply chain risks, leading to an unpredictable and unstable market environment. This dependence complicates planning and forecasting efforts, making it difficult for businesses to navigate the evolving landscape and maintain consistent operational efficiency in the face of these external pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a progressive trend of regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is leading to an evolving market landscape where smaller to mid-sized manufacturers are emerging in the Asia-Pacific region, enhancing production capabilities and market penetration. Concurrently, there is a noticeable resurgence of demand in North America and Europe, driven by a growing emphasis on supply security and reliability. This dual approach not only fosters competitive pricing and innovation but also establishes a more resilient supply chain framework within the ibuprofen API sector, reshaping global trade dynamics.

Product Code: SQMIG35I2474

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Pharmaceuticals
  • Consumer Healthcare
  • Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2025-2032)

  • Market Overview
  • Tablets
  • Oral
  • Suspension
  • Topical

Global Ibuprofen API Market Size & CAGR (2025-2032)

  • North America (Application, Formulation Type)
    • US
    • Canada
  • Europe (Application, Formulation Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, Formulation Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, Formulation Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, Formulation Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • BASF SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shandong Xinhua Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solara Active Pharma Sciences Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SI Group, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Granules India Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Strides Pharma Science Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOCAUSE Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mallinckrodt Pharmaceuticals (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SMS Pharmaceuticals Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wanbury Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aurobindo Pharma Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jubilant Life Sciences Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!